Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 16, Issue 4, 2017, Pages 483-487

  DaCosta, Alison ^a   Jordan, Cameron L ^a   Giddings, Olivia ^b   Lin, Feng Chang ^c   Gilligan, Peter ^a   Esther, Charles R ^b  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

Author keywords

Cystic fibrosis; Mycobacterium abscessus; Nontuberculous mycobacterium

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFOXITIN; CLARITHROMYCIN; IMIPENEM; LINEZOLID; TIGECYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; LUNG FUNCTION; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NONHUMAN; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SPUTUM CULTURE; TREATMENT DURATION; TREATMENT OUTCOME; ATYPICAL MYCOBACTERIOSIS; CHILD; DRUG EFFECTS; DRUG MONITORING; FEMALE; ISOLATION AND PURIFICATION; LUNG FUNCTION TEST; MALE; MICROBIOLOGY; PROCEDURES; SPUTUM; UNITED STATES;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CLARITHROMYCIN; CYSTIC FIBROSIS; DRUG MONITORING; FEMALE; HUMANS; MALE; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM; TREATMENT OUTCOME; UNITED STATES;

EID: 85019020652     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2017.04.013     Document Type: Article

References (22)

1. Bar-On, O., Mussaffi, H., Mei-Zahav, M., Prais, D., Steuer, G., Stafler, P., et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros 14 (2015), 53–62.
2. Olivier, K.N., Weber, D.J., Wallace, R.J. Jr., Faiz, A.R., Lee, J.H., Zhang, Y., et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 167 (2003), 828–834.
3. Adjemian, J., Olivier, K.N., Prevots, D.R., Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med 190 (2014), 581–586.
4. Griffith, D.E., Aksamit, T., Brown-Elliott, B.A., Catanzaro, A., Daley, C., Gordin, F., et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175 (2007), 367–416.
5. Leung, J.M., Olivier, K.N., Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis. Curr Opin Pulm Med 19 (2013), 662–669.
6. Esther, C.R. Jr., Esserman, D.A., Gilligan, P., Kerr, A., Noone, P.G., Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 9 (2010), 117–123.
7. Floto, R.A., Olivier, K.N., Saiman, L., Daley, C.L., Herrmann, J.L., Nick, J.A., et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax 71:Suppl. 1 (2016), i1–22.
8. Colin, A.A., Ali-Dinar, T., Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up. Pediatr Pulmonol 45 (2010), 626–627.
9. Jeon, K., Kwon, O.J., Lee, N.Y., Kim, B.J., Kook, Y.H., Lee, S.H., et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 180 (2009), 896–902.
10. Koh, W.J., Jeon, K., Lee, N.Y., Kim, B.J., Kook, Y.H., Lee, S.H., et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 183 (2011), 405–410.
11. Jarand, J., Levin, A., Zhang, L., Huitt, G., Mitchell, J.D., Daley, C.L., Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 52 (2011), 565–571.
12. Wallace, R.J. Jr., Dukart, G., Brown-Elliott, B.A., Griffith, D.E., Scerpella, E.G., Marshall, B., Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother 69 (2014), 1945–1953.
13. Olivier, K.N., Shaw, P.A., Glaser, T.S., Bhattacharyya, D., Fleshner, M., Brewer, C.C., et al. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Ann Am Thorac Soc 11 (2014), 30–35.
14. Waters, V., Ratjen, F., Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database Syst Rev, 12, 2014, CD010004.
15. Esther, C.R. Jr., Henry, M.M., Molina, P.L., Leigh, M.W., Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 40 (2005), 39–44.
16. Esther, C.R. Jr., Hoberman, S., Fine, J., Allen, S., Culbreath, K., Rodino, K., et al. Detection of rapidly growing mycobacteria in routine cultures of samples from patients with cystic fibrosis. J Clin Microbiol 49 (2011), 1421–1425.
17. Martiniano, S.L., Nick, J.A., Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med 36 (2015), 101–115.
18. Martiniano, S.L., Sontag, M.K., Daley, C.L., Nick, J.A., Sagel, S.D., Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc 11 (2014), 36–44.
19. Choi, G.E., Shin, S.J., Won, C.J., Min, K.N., Oh, T., Hahn, M.Y., et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med 186 (2012), 917–925.
20. Maurer, F.P., Castelberg, C., Quiblier, C., Bottger, E.C., Somoskovi, A., Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus. J Antimicrob Chemother 69 (2014), 1559–1563.
21. Nick, J., Sagel, S., Daley, C., Ellington, S., Holbrook, S., Martiniano, S., Prospective algorithm for treatment of nontuberculous mycobacteria in cystic fibrosis (patience) trial. Pediatric pulmonology, 2015, Wiley-Blackwell, 111 River St, Hoboken 07030–5774, NJ USA, 303–304.
22. Martiniano, S.L., Nick, J.A., Daley, C.L., Nontuberculous mycobacterial infections in cystic fibrosis. Clin Chest Med 37 (2016), 83–96.